Search Results 831-840 of 16052 for pharmacogenetics
The purpose of this study is to evaluate different strategies of cardiovascular therapy with Carvedilol, aiming to reduce the incidence of left ventricular ...
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...
The purpose of this study is to assess the effectiveness of an intervention program promoting emotional and cognitive health to modify high levels of perceived ...
We are currently enrolling both healthy volunteers and people who have been diagnosed with heart failure to participate in our research study.
Dr. Harris' Polycystic Kidney Disease Discovery Lab at Mayo Clinic focuses its ADPKD research on genetic analyses of human disease populations and animal ...
Quantitative Health Sciences at Mayo Clinic has three divisions handling epidemiology, biostatistics and informatics plus a biomedical ethics section.
Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...
The purpose of this study is to determine if psychosine (PSY) is an indicator of Krabbe disease status and predictor of disease progression. Participation ...
Mayo Clinic geriatrician and hospitalist Sandeep R. Pagali, M.D., M.P.H., explores ways to improve care for older adults in the hospital and at home, ...
For more information and all your COVID-19 coverage, go to the Mayo Clinic News Network and mayoclinic.org. Largest pharmacogenetic clinical trial in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.